Photodynamic Therapy in Bowen's Disease: Influence of Histological Features and Clinical Characteristics on Its Success

被引：23
作者：
Westers-Attema, Annet [1 ,2 ]
Lohman, Bjorn G. P. M. [2 ,3 ]
van den Heijkant, Fleur [1 ]
Nelemans, Patty J. [4 ]
Winnepenninckx, Veronique J. [2 ,3 ]
Kelleners-Smeets, Nicole W. J. [1 ,2 ]
Mosterd, Klara [1 ,2 ]
机构：
[1] Maastricht Univ, Med Ctr, Dept Dermatol, NL-6202 AZ Maastricht, Netherlands
[2] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, NL-6202 AZ Maastricht, Netherlands
[3] Maastricht Univ, Med Ctr, Dept Pathol, NL-6202 AZ Maastricht, Netherlands
[4] Maastricht Univ, CAPHRI, Dept Epidemiol, NL-6202 AZ Maastricht, Netherlands
来源：
DERMATOLOGY | 2015年 / 230卷 / 01期
关键词：
Bowen's disease; Photodynamic therapy; Epidermal thickness; Cell atypia; Age; BASAL-CELL CARCINOMA; SURGICAL EXCISION; TUMOR THICKNESS; GUIDELINES; EXPERIENCE; CANCER; LASER;
D O I：
10.1159/000366500
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Background: In Bowen's disease (BD) there is no consensus on optimal treatment. Photodynamic therapy (PDT) is an effective non-invasive treatment modality for BD with excellent cosmetic results. Objective: This retrospective study examines whether clinical and histological features of BD impact PDT response. Methods: Patients with previously untreated BD from 2002 until 2007 were identified at the Maastricht University Medical Centre. Patients treated with PDT were included. All histological slides were re-examined. Results: During the study period 98 tumours were treated with PDT. In univariate analysis severe atypia and higher age were associated with decreased probability of clinical clearance. Higher age was also associated with an increased risk of recurrence. In multivariate analysis severe atypia remained the only independent risk factor for therapy failure. Conclusion: In patients with BD, severe atypia and higher age are associated with an increased risk of treatment failure after PDT. (C) 2014 S. Karger AG, Basel
引用
收藏
页码：55 / 61
页数：7
相关论文
共 30 条
[1]  
Arlette John P, 2004, Australas J Dermatol, V45, P1, DOI 10.1111/j.1440-0960.2004.00025.x
[2]  
Arlette JP, 2004, AUSTRALAS J DERMATOL, V45, P10
[3]  
Bath-Hextall FJ, 2013, COCHRANE DB SYST REV, V6, DOI DOI 10.1002/14651858.CD007281.PUB2
[4]   Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma and precursor lesions [J].
Bonerandi, J. J. ;
Beauvillain, C. ;
Caquant, L. ;
Chassagne, J. F. ;
Chaussade, V. ;
Clavere, P. ;
Desouches, C. ;
Garnier, F. ;
Grolleau, J. L. ;
Grossin, M. ;
Jourdain, A. ;
Lemonnier, J. Y. ;
Maillard, H. ;
Ortonne, N. ;
Rio, E. ;
Simon, E. ;
Sei, J. F. ;
Grob, J. J. ;
Martin, L. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2011, 25 :1-51
[5]   PRE-CANCEROUS DERMATOSES - A STUDY OF 2 CASES OF CHRONIC ATYPICAL EPITHELIAL PROLIFERATION [J].
BOWEN, JT .
ARCHIVES OF DERMATOLOGY, 1983, 119 (03) :243-260
[6]   Photosensitizers and light sources for photodynamic therapy of the Bowen's disease [J].
Calin, M. A. ;
Diaconeasa, A. ;
Savastru, D. ;
Tautan, M. .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 2011, 303 (03) :145-151
[7]   Methylaminolaevulinate-based photodynamic therapy of Bowen's disease and squamous cell carcinoma [J].
Calzavara-Pinton, P. G. ;
Venturini, M. ;
Sala, R. ;
Capezzera, R. ;
Parrinello, G. ;
Specchia, C. ;
Zane, C. .
BRITISH JOURNAL OF DERMATOLOGY, 2008, 159 (01) :137-144
[8]   Cutaneous squamous cell carcinoma: a comprehensive clinicopathologic classification - Part two [J].
Cassarino, DS ;
DeRienzo, DP ;
Barr, RJ .
JOURNAL OF CUTANEOUS PATHOLOGY, 2006, 33 (04) :261-279
[9]   Guidelines for management of Bowen's disease: 2006 update [J].
Cox, N. H. ;
Eedy, D. J. ;
Morton, C. A. .
BRITISH JOURNAL OF DERMATOLOGY, 2007, 156 (01) :11-21
[10]   PATHOLOGICAL PROGNOSTIC FACTORS IN BREAST-CANCER .1. THE VALUE OF HISTOLOGICAL GRADE IN BREAST-CANCER - EXPERIENCE FROM A LARGE STUDY WITH LONG-TERM FOLLOW-UP [J].
ELSTON, CW ;
ELLIS, IO .
HISTOPATHOLOGY, 1991, 19 (05) :403-410
123